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Pain possesses both sensory and aﬀective dimensions, which are highly correlated yet distinct. Comparison of these dimensions
within experimental pain settings has resulted in the construct of relative unpleasantness. Relative unpleasantness is deﬁned as the
amount of aﬀective unpleasantness elicited for a given sensory magnitude. The aim of this study was to determine the relationship
between aﬀective and sensory components of evoked pain in subjects with ﬁbromyalgia (FM) and healthy controls. Here we show
that patients with FM unexpectedly display less relative unpleasantness than healthy controls in response to random noxious pres-
sure stimuli. Relative unpleasantness was not correlated with distress, anxiety, or depression, which were pronounced in the FM
group. Clinical pain in patients with FM was perceived to be more unpleasant than the evoked pain stimuli. These results are con-
sistent with the concept that chronic pain may reduce the relative unpleasantness of evoked pain sensations.
 2004 Published by Elsevier Ltd on behalf of European Federation of Chapters of the International Association for the Study of
Pain.
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Pain is a sensation that is composed of distinct yet in-
ter-related dimensions. Pain can be described in terms of
its intensity or sensory qualities as well as its emotional
or aﬀective aspects, which are integral to the sensation.
Primary aﬀective pain is believed to occur over a short
period of time and is related to the minute-by-minute
appraisal of pain, whereas secondary aﬀective pain in-
volves both past and future long-term reﬂection of the
sensation or condition. A ﬁnal cognitive-evaluative1090-3801/$30  2004 Published by Elsevier Ltd on behalf of European Fed
Pain.
doi:10.1016/j.ejpain.2004.09.001
* Corresponding author. Tel.: +1 734 763 7518; fax: +1 734 615
0611.
E-mail address: rgracely@med.umich.edu (R.H. Gracely).dimension integrates both past experiences and judg-
ments and exerts control over activity of both the sen-
sory and aﬀective systems (Melzack and Casey, 1968).
This model has evolved from studies of both experimen-
tal and clinical pain (reviewed in: Fields, 1999; Gracely,
1999; Price, 2000).
Diﬀerent clinical pain states can have distinct sensory
and aﬀective qualities. Price et al. (1987) observed that
althoughwomen in labor and cancer patients experienced
pain of similar sensory intensity, the aﬀective component
or unpleasantness of their pain was markedly diﬀerent.
Cancer patients reportedmore unpleasantness associated
with their pain than did women in labor. Furthermore the
unpleasantness that women in labor experienced was
altered by their cognitive state. Accordingly, attentioneration of Chapters of the International Association for the Study of
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ceptions (Malow, 1981; Miron et al., 1989; Keogh and
Mansoor, 2001; Geisser et al., 2003).
Investigations of experimentally induced pain have
also shown a divergence between pain dimensions (Grac-
ely et al., 1979; Rainville et al., 1992) and this separation
may be manifested in diﬀerent cortical brain regions and
modulated by diﬀerent neurotransmitters. For example,
the neural activity in the somatosensory cortex (S1) ap-
pears to correlate with pain intensity (Hofbauer et al.,
2001) while activity in the anterior cingulate cortex
(ACC) and other limbic structures may be the locus for
unpleasantness (Rainville et al., 1997). Similarly, the
aﬀective and sensory components of pain are diﬀerentially
modulated by pharmacologic therapies (Gracely et al.,
1979). Given this divergence of sensory and aﬀective as-
pects for both clinical and experimental pain, it is useful
to deﬁne the measure of relative unpleasantness as a con-
struct to assess this diﬀerence (Rainville et al., 1992). Rel-
ative unpleasantness can be thought of as ‘‘how much a
given sensation bothers you’’ (Gracely, 1992).
Strong aﬀective elements make the syndrome of
ﬁbromyalgia (FM) ideal for examining diﬀerences in
pain intensity and unpleasantness in both experimental
and clinical settings. FM is deﬁned by the presence of
chronic, widespread pain, and the ﬁnding of generalized
tenderness or increased pressure pain sensitivity on
examination, as assessed by a tender point exam (Wolfe
et al., 1990). A positive exam is deﬁned by the presence
of evoked pain at 11 out of 18 tender points when 4 kg
of pressure is applied. In addition, FM patients com-
monly have high levels of psychological aﬀective symp-
toms, such as anxiety and depression (Boissevain and
McCain, 1991; Epstein et al., 1997), which could be an
independent feature of the syndrome and/or a result
from secondary aspects of this chronic condition. A
complicating factor in FM studies is that the number
of positive tender points has been shown to be inﬂu-
enced by an individuals subjective level of distress, so
studies designed to isolate the aﬀective component of
the pain experience must control for this association
(Wolfe, 1997; Petzke et al., 2003b).
More sophisticated experimental pain assessment
methodologies may provide insight into the aﬀective
component of the pain experience in ﬁbromyalgia. Most
experimental pain studies in FM to date have used an
‘‘ascending’’ testing paradigm, such as manual tender
point counts or dolorimetry, wherein the stimulus inten-
sity is increased in a predictable manner (Bendtsen et al.,
1997). Not surprisingly, subject and observer factors
such as expectancy, aﬀective state, or hypervigilance
can inﬂuence pain report in these ascending paradigms
(McDermid et al., 1996; Wolfe, 1997). Random testing
paradigms, in which the next stimulus cannot be antici-
pated, have been shown to reduce these confounding
factors (Petzke et al., 2003a,b), and are thought to min-imize the biasing eﬀect of distress in determining a
patients degree of tenderness.
This study quantitatively describes the sensory inten-
sity and aﬀective unpleasantness components of evoked
pressure pain in FM subjects and healthy controls (HC).
Ratings were obtained from both ascending and random
methods of stimulus presentation to evaluate the role of
bias as outlined above. The speciﬁc focus was to deter-
mine if FM subjects had altered pain unpleasantness
in response to evoked pressure stimuli relative to HC
and if this diﬀerence would be correlated with measures
of distress, dysfunction and clinical pain.2. Materials and methods
2.1. Subjects
Patients under treatment at the Georgetown Univer-
sity Medical Center for an established diagnosis of FM
were invited to participate in the study. Concurrent
inﬂammatory rheumatic conditions or severe other med-
ical conditions were criteria for exclusion. HC subjects
were recruited through ﬂyers and newspaper advertise-
ments, compensated for their participation, and
matched by age and sex to the patient population. Prior
to the study, all participants read and signed an in-
formed consent form. The Georgetown University Insti-
tutional Review Board approved the consent form and
study protocols.
Because previous studies have shown diﬀerences in
pain report for women at diﬀerent stages in the menstrual
cycle (Bajaj et al., 2001, 2002; Riley et al., 1999), all female
participants were screened for menstrual status on the
day of pain testing. They were asked about menstrual his-
tory, average cycle length, last menstrual period, and use
of medications (birth control pill, hormone replacement
therapy). Cycle stages were grouped into menstruation,
follicular (including midcycle), luteal (including premen-
strual), and postmenopausal (including perimenopausal
women, and subjects with hysterectomy).
For patients with FM the presence of chronic wide-
spread pain was conﬁrmed, and a manual tender point
count performed. Only patients that satisﬁed the ACR
criteria (Wolfe et al., 1990) of at least 11 of 18 positive
tender points were included in the analysis. All control
subjects underwent a tender point examination and were
excluded if they had a tender point count of 11 or great-
er or a history of any current or chronic pain of greater
than one-week duration.
2.2. Psychophysical testing – overview
Upon arrival to the research center all subjects were
shown and oriented to the experimental pain-testing envi-
ronment. During that time the consent form was signed
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Fig. 1. Aﬀective and sensory numerical descriptor scales used to
measure evoked pain dimensions of aﬀective unpleasantness and
sensory intensity.
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tory obtained, and subjects were asked about current
medications and their intake in the last 24 h. Patients par-
ticipating in pain testing were allowed to continue their
regular medication. However, they were advised not to
take any analgesics for 24 h prior to the testing session.
Healthy controls were also asked not to take any analge-
sic medication 24 h prior to the pain testing.
The pain testing equipment was demonstrated and
explained using a ‘‘scripted’’ text. A few discrete pres-
sure stimuli were applied to familiarize subjects with
the procedure. The instructions for the diﬀerent tests
also followed a standardized script and additional infor-
mation and explanations were provided if required. The
sequence of testing was the same for all subjects.
2.3. Pressure pain testing
A dolorimeter exam at the 18 deﬁned tender points,
and four control points (the bilateral thumbs and ante-
rior tibial muscles) was performed on all subjects (Wolfe
et al., 1990) using a 3.14 cm2 footplate size. Pressure was
increased at a rate of 1 kg/s and subjects were instructed
to indicate when they ﬁrst perceived pain. If no pain re-
sponse was elicited up to 12 kg of pressure, this value
was recorded as the pain threshold. The average pres-
sure pain threshold for all 18 tender point sites was cal-
culated and expressed as kg/3.14 cm2.
Discrete pressure stimuli were applied using a remote
stimulation device to eliminate any direct examiner/sub-
ject interaction. The apparatus induced pressure with a
hydraulic system in which a 1 cm2 hard rubber circular
probe was pressed against the left or right thumbnail
(see below). The thumbnail was chosen as it has been
shown to be more sensitive to pressure in FM subjects
than in HC (Petzke et al., 2001), and remains a ‘‘neutral’’
point for patients with FM compared to a typical tender
point. The stimulator was positioned over the thumb by
a plastic housing and the hydraulic system activated by
calibrated weights placed on a moveable table. Valves
controlled stimulus timing. The combination of valves
and calibrated weights produced controlled, repeatable
stimulation that approached a rectangular waveform.
To compare the eﬀect of stimulus presentation on
unpleasantness and intensity ratings, both an ascending
and a random series were performed on each subject.
2.3.1. Discrete ascending pressure
For the ascending series (ASC), discrete stimuli of 5 s
duration were applied to the right thumbnail. Initial
stimulation pressure was 0.45 kg and stimulation pres-
sure was increased in 0.45 kg increments up to either a
subjects level of pain tolerance or a maximum of 9.1
kg. Subjects used two 21-box numerical descriptor scales
to rate the intensity and then the unpleasantness of sen-
sations evoked by each stimulus (see Fig. 1). After sub-jects had rated a stimulus with a pain intensity of greater
than 10 (mild to moderate pain), they were asked if they
wished to continue after each succeeding stimulus. Inter-
stimulus interval was 30 s.
2.3.2. Discrete random pressure
For the random series (RAN), subjects were in-
structed that they would receive a diﬀerent series of
stimuli within the range of the previous ascending series.
If tolerated, seven stimuli (0.45, 0.91, 1.36, 1.82, 2.73,
3.64, 4.54 kg) were twice presented in random order to
the left thumb and ratings of sensory intensity and
unpleasantness were obtained using the 21-box scales.
Four subjects with FM received less than the seven stim-
uli (1 only four stimuli, and 3 only 6 stimuli). In both pa-
tients and controls this weight distribution resulted in at
least three values between pain threshold and tolerance.
Inter-stimulus interval was 30 s.
2.4. Pain intensity and unpleasantness estimation
Pain intensity and unpleasantness ratings in response
to discrete stimuli were recorded on two separate 21-box
numerical descriptor scales (Fig. 1) using standardized
instructions, similar to Price et al. (1984). These scales
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descriptors (Gracely et al., 1978a,b, 1979). They posses
logarithmic properties with regard to the spacing of
the descriptors, and had been shown to be sensitive in
other studies (Eliav and Gracely, 1998; Sternberg
et al., 1998; Gracely et al., 2002; Lembo et al., 2000; Pet-
zke et al., 2003a).
In addition to the two 21-box scales described above,
experimental pain was also assessed with the Short
Form of the McGill pain questionnaire (MPQ:SF). Sub-
jects were asked to rate the worst pain experienced dur-
ing the two prior testing sessions (ASC; RAN). Thus the
subjective ratings were not in response to a speciﬁc stim-
ulus but reﬂected the retrospective perception and expe-
rience during the two evoked pain paradigms.
2.5. Questionnaires
2.5.1. Functional status
The SF-36, is a brief, well-established, self-adminis-
tered patient questionnaire for the assessment of health
status (Ware et al., 2000). The SF-36 measures eight do-
mains of health status, and summary physical (PCS) and
mental health (MCS) scales can be calculated by com-
bining and weighting the various individual scales.
These summary scales are standardized to have a
mean = 50, SD = 10 in the general US population (Ware
and Kosinski, 2001).
2.5.2. Depressive symptoms
Neurovegetative and cognitive symptoms of depres-
sion were evaluated by the Beck Depression Inventory
(BDI), a 21-item measure of the severity of current
depressive symptoms that has been validated for use in
rheumatic diseases (Burckhardt et al., 1994).
2.5.3. Distress
The Brief Symptom Inventory (BSI) was used to ob-
tain an indicator of distress (Derogatis and Spencer,
1983). This 51-item instrument contains nine sub-scales
and a Global Severity Index (GSI), which was used as
a general measure for distress; the anxiety sub-scale
was used to measure an individuals anxiety.
2.5.4. Clinical pain
Clinical pain was assessed by the Short Form of the
McGill pain questionnaire (MPQ:SF). This 15-item
inventory yields both a sensory and aﬀective subscale
(Melzack, 1987). Scores were expressed as % of the max-
imum possible score for each dimension (Stohler and
Kowalski, 1999).
2.6. Statistical analysis
Statistical analyses were performed in several stages:
(1) Descriptive statistics deﬁning similarities and diﬀer-ences between the FM and healthy control groups, (2)
Analyses comparing pain intensity and unpleasantness
between the FM and HC groups in the ASC and
RAN series of tests, (3) Analyses comparing the relative
unpleasantness between the FM and HC groups, (4)
Analyses addressing the inﬂuence of diﬀerences in mean
pain intensity between the two groups on the relative
unpleasantness, (4) Analyses exploring associations be-
tween relative unpleasantness and aﬀective symptoms,
and (5) the relative unpleasantness of clinical compared
to evoked pain in patients with FM.2.6.1. Comparison of pain intensity and unpleasantness
To compare responses in the discrete pressure testing
paradigms (ASC, RAN), the areas under the stimulus
response curve (AUC) for pain intensity and unpleas-
antness for the 0.45–4.5 kg stimulus range were calcu-
lated for both groups. Since the curve was deﬁned as a
set of stimulation pressures (xi) and corresponding pain
ratings (yi), the AUC was calculated as follows:
AUC =
P
(((y(i + 1) + yi)/2) · (x(i + 1)xi)). The sum in-
cluded all available data points in a given stimulus
range. In subjects who could not complete the whole
testing range the highest pain intensity or unpleasant-
ness rating was substituted for the missing values (only
six values in four FM subjects).2.6.2. Relative unpleasantness
Relative unpleasantness is typically deﬁned as the ra-
tio of unpleasantness to intensity ratings (unpleasant-
ness/intensity; (Rainville et al., 1992)). Since the box
scales we used possess logarithmic properties (Gracely
et al., 1978a), relative unpleasantness was calculated as
the diﬀerence of unpleasantness minus intensity, which
corresponds to a ratio in arithmetic units. We calculated
the mean relative unpleasantness as the AUC for
unpleasantness ratings minus the AUC for intensity
ratings.
Relative unpleasantness for clinical and evoked pain
ratings with the MPQ:SF in patients with FM was also
calculated. The respective MPQ:SF % scores were used
as follows: %aﬀective score/%sensory score.2.6.3. Mean perceived pain intensity and range restriction
The restriction of stimulus intensity to a range from
0.45 to 4.5 in ASC and RAN was necessary to allow
the comparison of the average group responses. With re-
spect to the relationship between ratings of pain inten-
sity and unpleasantness in the two groups, this range
restriction could result in a scaling bias due to the group
diﬀerence in pain sensitivity, with FM patients typically
using higher scale values than HC. Therefore the mean
perceived pain intensity was calculated for ASC and
RAN and correlated with the respective relative
unpleasantness.
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scales across the whole individual rating range of the
AUCs, the relative unpleasantness and the mean per-
ceived pain intensity were also calculated for all availa-
ble responses in the ascending paradigm up to individual
tolerance or the stimulus maximum of 9.1 kg (ASC-
TOL) in both groups.
2.7. Statistical procedures
t-Tests and v-square tests were used to characterize
the demographic (e.g. age, sex,), clinical pain character-
istics (menstrual status, disease duration, MPQ:SF pain
scores, tender point and dolorimetry scores), and aﬀec-
tive measures (BDI, BSI). ANOVAs were used to evalu-
ate whether unpleasantness or relative unpleasantness
diﬀered between groups and across pain-evoking para-
digms. Correlational analyses were used to explore asso-
ciative relationships between relative unpleasantness
and mean perceived pain intensity, and aﬀective varia-
bles. All data are expressed as mean ± SEM unless sta-
ted otherwise. Data analysis was performed with SPSS
11.0 and MS Excel.3. Results
3.1. Subjects
The 43 clinic patients included in the study fulﬁlled
the ACR criteria for FM on the day of testing. Subjects
were age and gender matched with 28 healthy control
subjects (Table 1). The observed slight diﬀerence in
age was not statistically signiﬁcant (p = 0.26) nor was
the proportion of males to females (p = 0.75). Distribu-
tion of menstrual status in the two groups was similar:
62% of patients and 50% of controls were postmenopau-
sal; cycle stages in the remaining subjects were evenly
distributed between the two groups and not statisticallyTable 1
Clinical characteristics of the two subject groups: age, male/female ratio, a
(mean ± SDV)
Fibromyalgia patien
Age (years) 49.7 ± 11.7
Male (N)/Female (N) 4/39
Disease duration (years) 10.5 ± 8.0
Regional pain score 40.9 ± 16.8
MPQ:SF – total score 18.3 ± 8.2
MPQ:SF – sensory score 14.7 ± 6.1
MPQ:SF – aﬀective score 3.8 ± 3.1
BSI Global Severity Index 63.8 ± 1.4
BDI 15.3 ± 10.1
Manual tender point count 14.3 ± 0.34
(range) [11–18]
Dolorimetry pain threshold (kg/3.14 cm2) 4.47 ± 0.22signiﬁcantly diﬀerent (v-square p = 0.29). Not surpris-
ingly, FM subjects displayed statistically signiﬁcant
greater clinical pain scores (MPQ:SF), depression, dis-
tress, and tenderness compared to controls. Only four
of the healthy controls had more than four positive ten-
der points on manual palpation.
3.2. Pressure thresholds – dolorimetry on thumb and
tender points
As expected, all pressure pain thresholds were signif-
icantly higher in the control subjects than in the FM pa-
tients (Table 1; 8.5 ± 0.35 vs. 4.5 ± 0.2 kg/cm2 for tender
points; 10.0 ± 0.4 vs. 6.1 ± 0.4 kg/cm2 for right thumb;
10.6 ± 0.4 vs. 6.1 ± 0.4 kg/cm2 for left thumb; all
p < 0.0001). Within the groups, measures at the thumbs
and tender points were highly inter-correlated; more so
in the patient group (r = 0.73–0.93; all p < 0.0001) than
in the controls (r = 0.54–0.73; all p < 0.003) possibly
due to range restriction in the latter group.
3.3. Unpleasantness and pain intensity
3.3.1. ASC
Patients with FM had higher AUC summary ratings
than healthy controls for both unpleasantness and pain
intensity in the ascending paradigm (Fig. 2(a)). A 2 · 2
ANOVA of group X pain dimension revealed signiﬁcant
main eﬀects for group (FM > HC, F[1,69] = 30.3,
p < 0.001) and dimension (Unpleasantness > Intensity,
F[1,69] = 5.1, p < 0.03), but no signiﬁcant interaction
(F[1,69] = 0.9, p = 0.35). This indicated that the diﬀer-
ence between unpleasantness and intensity within both
groups was similar.
3.3.2. RAN
Similar to the ASC paradigm, patients with FM had
an increased AUC for unpleasantness and intensity
compared to HC for RAN (Fig. 2(b)). A 2 · 2 ANOVAverage subject questionnaire responses, and standard pain measures
ts, N = 43 Healthy controls, N = 28 p
46.8 ± 9.5 n.s.
2/26 n.s.
– –
1.1 ± 0.4 0.0001
0.4 ± 0.1 0.0001
0.4 ± 0.1 0.0001
0.0 ± 0.0 0.0001
46.2 ± 1.9 0.0001
2.7 ± 0.6 0.0001
2.1 ± 0.57 0.0001
[0–8]
8.55 ± 0.35 0.0001
Fig. 2. Pain intensity (PI) and unpleasantness (UP) ratings for FM
and HC expressed as area under the curve (AUC) ±1 SEM. (a) ASC –
The FM group displayed greater PI and UP compared to HC
(PI = 52.1 ± 4.99 FM, 16.3 ± 2.36 HC; UP = 54.5 ± 4.70 FM,
22.3 ± 3.28 HC), however there was no signiﬁcant interaction. (b)
RAN – Similar to the ASC paradigm, the FM group had greater PI
and UP compared to HC (PI = 72.04 ± 4.62 FM, 41.6 ± 5.91 HC;
UP = 62.3 ± 4.56 FM, 41.2 ± 6.17 HC). However within groups, FM
subjects displayed less UP than PI as compared to HC (* signiﬁcant
interaction).
Fig. 3. Relative unpleasantness (AUC for UP minus AUC for PI) ±1
SEM in the two paradigms: For ASC a students t-test revealed no
signiﬁcant diﬀerence (p = 0.35) between FM (2.44 ± 2.48) and HC
(5.96 ± 2.62). However for RAN, relative unpleasantness was signif-
icantly less for FM as compared to HC (RAN: *p < 0.007,
9.75 ± 2.33 FM, 0.41 ± 2.05 HC).
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main eﬀects for group (FM > HC, F[1,69] = 12.5,
p < 0.001) and pain dimension, however the dimension
eﬀect was reversed in direction (unpleasantness < inten-
sity, F[1,69] = 9.3, p < 0.003) as compared to the ASC
paradigm. A signiﬁcant group X dimension interaction
(F[1,69] = 7.9, p = 0.007) was detected indicating that
the diﬀerence between unpleasantness and intensity rat-
ings within the FM group diﬀered from the HC group.
3.4. Relative unpleasantness
The diﬀerence in degree and direction of the interac-
tion between group X pain dimensions seen in Fig. 2 is
explained by Fig. 3, which shows the relative unpleas-
antness for ASC and RAN. Patients with FM displayed
generally less relative unpleasantness and this diﬀerence
was signiﬁcant and pronounced in the random para-
digms (p < 0.01).
We compared relative unpleasantness in ASC and
RAN using a 2 · 2 ANOVA to analyze the eﬀect of pain
testing methodology. A signiﬁcant main eﬀect for group
was observed (FM < HC: F[1,69] = 4.0, p < 0.05). The
eﬀect of method (ASC > RAN) was also highly signiﬁ-cant (F[1,69] = 37.8, p < 0.0001), while the group-
method interaction approached signiﬁcance (F[1,69] =
3.7, p = 0.06). These ﬁndings indicate (1) that both pa-
tients with FM and HC described equally intense pain
sensations as more unpleasant in the ascending para-
digm compared to the less predictable random para-
digm, (2) that this diﬀerence between paradigms is
more pronounced in patients with FM and (3) that pa-
tients with FM report generally less relative unpleasant-
ness than HC.
The above data indicated that with random stimulus
presentation, despite overall higher pain and unpleas-
antness ratings than HC, FM patients had relatively less
unpleasantness compared to HC. This can also be visu-
alized by plotting the mean unpleasantness score versus
the mean pain intensity score for all pressures eliciting a
painful sensation (mean pain intensity score >0.5 repre-
senting faint pain) in the ASC (Fig. 4(a)) and RAN par-
adigms (Fig. 4(b)). Mean scores in the ascending
paradigm showed a similar linear pattern in both
groups, with the FM curve shifted towards higher val-
ues. However, FM mean scores in the random paradigm
consistently trended toward lower values along the aﬀec-
tive dimension, suggesting an additional parallel down-
ward shift in relative unpleasantness over the whole
stimulus–response curve.
Aﬀective and sensory sub-scale scores of evoked
experimental pain were also compared using the
MPQ:SF. Similar to the above ﬁndings, subjects with
FM reported relatively less evoked aﬀective pain as
measured by the MPQ:SF (Fig. 5: Evoked pain in
HC and FM). Although the sensory scores were signif-
icantly higher (FM > HC; p < 0.05), the aﬀective scores
were not statistically diﬀerent (p = 0.29). Thus, a com-
bination of a diﬀerent scale and a retrospective assess-
ment also showed that the relative unpleasantness of
evoked pain was again less for the FM subjects (i.e.
identical unpleasantness for an increased sensory
intensity).
Fig. 4. Aﬀective versus sensory plots: (a) ASC – 21-box scale mean
values ±1 SEM for aﬀective and sensory ratings for 0.91, 1.36, 1.82,
2.27, 2.73, 3.18, 3.64, 4.09, and 4.54 kg weights in FM and 2.27, 2.73,
3.18, 3.64, 4.09, and 4.54 kg weights in HC, representing stimuli
inducing an average pain intensity rating >0.5 (faint pain). FM
subjects tend to greater aﬀective and sensory scores but show a similar
stimulus-response curve. (b) RAN – 21-box scale mean values ±1 SEM
for aﬀective and sensory ratings in both groups for 0.45 (not in HC),
0.91, 1.36, 1.82, 2.73, 3.64, and 4.54 kg weights, representing stimuli
inducing an average pain intensity rating >0.5 (faint pain). FM subject
means tended toward lower aﬀective and greater sensory scores
resulting in a parallel downward shift of the stimulus–response curve.
Fig. 5. Retrospective ratings of experimental pressure pain (for HC
and FM) and clinical pain (for FM only) using the MPQ:SF aﬀective
and sensory sub-scales, expressed as % of possible maximum score.
FM and HC evoked pain: The sensory mean was greater in FM than
HC (p < 0.05: 32.2 ± 2.72 FM, 22.8 ± 2.98 HC), however the aﬀective
scores were not signiﬁcantly diﬀerent (p = 0.29: 8.14 ± 1.95 FM,
4.76 ± 2.55 HC). FM evoked and clinical pain: FM patients reported
more sensory and aﬀective clinical pain, with more relative unpleas-
antness compared to the evoked pain.
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perceived pain intensity
A signiﬁcant eﬀect of the pain testing methods on rel-
ative unpleasantness was found for both groups, with
higher relative unpleasantness ratings in the ascending
series (Fig. 3). However, overall ratings of unpleasant-
ness and pain intensity were higher in the random than
in the ascending paradigms for both groups (Figs. 2 and
4(a) and (b)). Therefore we examined the relationship
between mean perceived pain intensity and relative
unpleasantness for both FM and HC subjects (Table
2). The relative unpleasantness for patients with FMcorrelated negatively with perceived pain intensity in
the ASC and RAN paradigm, while HC displayed a sim-
ilar but non-signiﬁcant trend. This negative correlation,
however, was signiﬁcant for both groups in ASC-TOL
when the entire stimulus range that was delivered during
the ascending paradigm was evaluated. This relationship
is also evident in Figs. 4(a) and (b) if the position of
pressure stimuli in both groups is compared to the
bisecting line (indicating equal pain intensity and
unpleasantness). In Fig. 4(a), stimuli inducing higher
pain intensity ratings generally lie below this line (indi-
cating less relative unpleasantness) while stimuli induc-
ing lower pain intensity are positioned above
(indicating more relative unpleasantness). In Fig. 4(b)
the same relationship is seen, however, patients with
FM reported generally less unpleasantness resulting in
a parallel and downward curve shift (see above).
The combination of the restriction of the stimulus
range in the ASC and RAN paradigms and the negative
correlation of relative unpleasantness with pain intensity
may have contributed to the diﬀerences in relative
unpleasantness observed between patients with FM
and HC, but it fails to explain the increasing group dif-
ferences in relative unpleasantness in the random para-
digms with overall higher pain intensity and
unpleasantness ratings.
3.6. Correlation with psychometric measures
We examined the interaction of relative unpleasant-
ness with the psychological constituents of each sub-
ject to determine if psychological parameters could
account for the diﬀerences observed above. The
Table 3
Correlation between relative unpleasantness in the three paradigms, ASC-TOL and psychometric measures of distress (BSI-GSI), anxiety (BSI-sub-
scale), depression (BDI), and clinical pain (MPQ:SF aﬀective and sensory)
Relative unpleasantness
ASC RAN
HC FM HC FM
BSI-Anxiety r 0.18 0.14 0.1 0.01
p 0.37 0.37 0.62 0.96
BSI-GSI r 0.05 0.1 0.13 0.18
p 0.81 0.55 0.51 0.26
BDI r 0.06 0.03 0.10 0.17
p 0.76 0.85 0.63 0.29
MPQ:SF – Total score r 0.03 0.002 0.2 0.05
p 0.87 0.98 0.32 0.77
MPQ:SF – Sensory score r 0.03 0.01 0.2 0.02
p 0.87 0.98 0.32 0.92
MPQ:SF – Aﬀective score r n.a.a 0.01 n.a.a 0.01
p 0.52 0.97
a All HC had a MPQ:SF aﬀective score of 0.
Table 2
Correlation between relative unpleasantness and mean perceived pain intensity in the three paradigms, and ASC-TOL for both patients with FM and
HC
Relative unpleasantness
Mean perceived ASC RAN ASC- TOL
Pain intensity HC FM HC FM HC FM
ASC r 0.11 0.39 – –
p 0.56 0.009 – –
RAN r – – 0.23 0.26
p – – 0.24 0.09
ASC-TOL r 0.37 0.35
p 0.05 0.02
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relative unpleasantness in the ASC and RAN para-
digms and psychometric measures for anxiety, distress,
depression, and clinical pain are shown in Table 3.
None of the correlations were signiﬁcant in either
group.3.7. Evoked and clinical pain
The MPQ:SF provides the opportunity to compare
pain dimensions in both clinical and evoked settings
within the FM group (Fig. 5). For the FM subjects alone
a 2 · 2 ANOVA showed signiﬁcant main eﬀects for type
of pain (clinical > experimental, F[1,42] = 76.4, p <
0.0001), pain dimension (sensory > aﬀective, F[1,42] =
138.4, p < 0.001), and a highly signiﬁcant interaction
(F[1,42] = 68.0, p < 0.0001). Relative unpleasantness
was 0.83 ± 0.09 for clinical but only 0.23 ± 0.05 for
evoked pain (p < 0.0001). These results indicated that
clinical pain was more unpleasant than experimental
pain of a given sensory intensity.4. Discussion
This study examined two dimensions of pain, inten-
sity and unpleasantness, in both FM and HC subjects.
The primary ﬁnding from this investigation of noxious
pressure was that patients with FM reported greater
pain intensity but less relative unpleasantness as com-
pared to healthy controls. These results suggest that
although FM patients experience clinical pain on a reg-
ular basis, they are less bothered by pain in experimental
settings. This diﬀerence may be explained by multiple
factors, which may not be mutually exclusive.4.1. Why do FM subjects display relatively less
unpleasantness?
FM patients experience pain of a signiﬁcant magni-
tude for a prolonged duration of time. The mean dura-
tion of the disease for patients in this study was 10.5
years. Therefore the stimuli used in these experiments
might be perceived as relatively less unpleasant due to
F. Petzke et al. / European Journal of Pain 9 (2005) 325–335 333the fact that FM patients are simply more familiar with
painful sensations than controls. A similar explanation
could be that because the FM patients have already
experienced clinical pain unpleasantness of signiﬁcant
magnitude, they compare the evoked stimuli to their
greater clinical pain. Indeed in this study the FM sub-
jects using the MPQ:SF reported their clinical pain as
more unpleasant than evoked pain of similar intensity
(Fig. 5). This eﬀect seen in clinical pain subjects was pre-
dicted by Rollman and was termed adaptation (Roll-
man, 1979, 1983). He reasoned that subjects use their
clinical pain as a reference point for pain in experimental
settings. In contrast, this reference framework may be
missing in the control subjects.
In addition to an adaptation eﬀect operating during
the evaluation and rating of pain experience, it is also
possible that the relative unpleasantness observed with
FM may reﬂect modulation by intrinsic mechanisms
activated by persistent pain. For example, several stud-
ies have found that endogenous analgesic systems can
be activated in healthy controls but not in patients with
FM (Kosek et al., 1996; Lautenbacher and Rollman,
1997; Staud et al., 2003). Although often interpreted
as a disorder in intrinsic analgesia, this result is also con-
sistent with a state in which the persistent pain of FM
results in maximal tonic activation of endogenous anal-
gesic systems (Gracely et al., 2003), and that the reduc-
tion in relative unpleasantness observed with FM
reﬂects preferential modulation of pain unpleasantness.
Neither the adaptation nor this modulation mechanism
needs to be mutually exclusive and both mechanisms
could contribute to our results.
4.2. Why does random presentation diﬀer from ascending?
An interesting ﬁnding in this study was that diﬀer-
ences in relative unpleasantness were detected only
when the painful stimuli were presented in a random
fashion. When the stimuli were presented in a predict-
able ascending fashion there was no group X pain-
dimension interaction. Some of this diﬀerence might
be explained by the generally higher pain ratings from
FM patients for a given stimulus intensity and the
trend to less relative unpleasantness with higher pain
ratings in both groups (Table 2 and Fig. 4(a) and
(b)). But the similar linear pattern of mean pain inten-
sity and unpleasantness ratings of ascending pressure
stimuli present in both groups (Fig. 4(a)), is contrasted
by a parallel downward shift in unpleasantness ratings
in patients with ﬁbromyalgia in response to randomly
presented stimuli (Fig. 4(b)). Thus, mechanisms other
than the properties and range restriction of the pain
scales likely mediate the observed diﬀerence in relative
unpleasantness.
The cognitive context of the random and ascending
paradigms are clearly diﬀerent. In the ascending para-digm, subjects know that the intensity of the next stim-
ulus will be just slightly greater than the intensity of the
preceding stimulus. In contrast, the unpredictable qual-
ity of the random presentation results in a state of uncer-
tainty that may lead to exaggerated responses.
Unpredictable painful stimuli have been previously
shown to be more unpleasant than anticipated painful
stimuli (Price et al., 1980) and even non-painful stimuli
appear more unpleasant when presented in a random
fashion (Sawamoto et al., 2000). Our ﬁnding that ratings
of both intensity and unpleasantness were higher in the
random than the ascending series in both groups (Fig. 2)
is consistent with these previous results. At this point it
is important to realize that patients with FM were even
less inclined than HC to respond in an exaggerated fash-
ion, showing less relative unpleasantness in the random
paradigm and that this relative unpleasantness was not
correlated to any of the psychosocial or clinical pain
measures.
It is also conceivable that the diﬀerence between the
ascending and random paradigms reﬂects the eﬀects of
task demands in the ascending methods. Subjects
know that the stimulus intensity increases on succes-
sive trials, and thus likely adapt a response behavior
in which successive responses also increase. This
potentially produces results that are automatically
monotonic with stimulus intensity. Subjects can pro-
duce such data without even attending to the stimulus
(Gracely et al., 2003). This is an example of a ‘‘stimu-
lus-independent bias’’.
These data reinforce the notion that the manner in
which painful stimuli are presented can profoundly
inﬂuence how pain is reported. Pain report is not sim-
ply dependent upon the subject, but involves an inter-
action between the subject, experimenter, and
paradigm.
4.3. What is the relevance of this diﬀerence?
This question is complicated by the fact that pain is a
multidimensional sensation. One measure may detect
more of the sensory components of pain (i.e. intensity,
timing, or location) whereas another may be more sensi-
tive to the emotional or aﬀective dimension. Indeed dif-
ferent clinical interventions appear to diﬀerentially alter
the sensory and aﬀective components of pain (for review
(Fernandez and Turk, 1992) therefore it seems logical
that experimental paradigms may elicit diﬀerent dimen-
sions of the pain sensation as well.
Evidence suggests that the random protocol is less
biased by aﬀective and evaluative factors such as subject
hypervigilance or expectancy, and stimulus-independent
bias (Gracely et al., 2003). In contrast, ascending pain
paradigms such as the dolorimeter and tender point
count correlate more with a subjects psychological state
(Petzke et al., 2003b). Again this may play into the
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digms as compared to the ‘‘unknown’’ random para-
digms. Subjects know that the succeeding stimulus will
be more intense in the ascending paradigms and there-
fore may react diﬀerently to it. Evidence in support of
this hypothesis is presented here, where the relative
unpleasantness was signiﬁcantly more in the ascending
paradigms than in the random paradigms for both
groups (Fig. 3). This suggests that the ascending para-
digm evokes a greater aﬀective magnitude than the ran-
dom paradigm. This is somewhat counterintuitive, in
that as noted above the ratings for both intensity and
unpleasantness were higher in the random paradigm
than for the ascending, yet only the ascending para-
digms are related to measures of mood and distress
(Petzke et al., 2003b). These data suggest that other psy-
chological constructs, perhaps related to control, are
driving symptom report and lowering of pain ratings ob-
tained during ascending paradigms, and that these con-
structs aﬀect both healthy controls and patients with
ﬁbromyalgia in a similar manner.5. Conclusion
The dimensions of pain intensity and unpleasantness
are separate yet highly correlated. Results presented
here further support this hypothesis and in addition sug-
gest that the presence of a chronic pain state can alter
ones response to evoked pain. Indeed Rollman rea-
soned that chronic pain subjects may display a diﬀerent
‘‘adaptation-level’’ than normal subjects based on diﬀer-
ences in their ‘‘internal comparison’’ mechanisms of
pain stimuli (Rollman, 1979). As noted above FM sub-
jects may compare the experimental pain to their more
intense clinical pain and therefore rate the evoked sensa-
tions as less unpleasant.
Results presented here are consistent with those ob-
tained from other chronic pain states such as cancer
and causalgia (Price et al., 1987). In general clinical pain
is perceived as more unpleasant than experimentally
evoked sensations of similar magnitude. This raises the
hypothesis that diﬀering chronic pain conditions may
elicit similar changes in evoked pain perceptions, how-
ever uncovering the underlying mechanisms will require
further research.Acknowledgements
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